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Abstract
Overnight pulse oximetry (OPO) has proven to be an effective and beneficial technique to determine the
cardiorespiratory status of patients in both the inpatient and outpatient settings. It is a cheap, safe, reliable,
simple, and accurate method of patient monitoring as compared to the expensive and labor-intensive
method of multichannel polysomnography for detecting sleep-disordered breathing. It provides accurate
information about patient's oxygenation status and also helps in monitoring the response to continuous
positive airway pressure and in the surgical treatment of obstructive sleep apnea (OSA). Nocturnal
hypoxemia portends a poor prognosis in patients of chronic obstructive pulmonary disease (COPD),
interstitial lung disease (ILD), and neuromuscular diseases. OPO can help its early detection and
management.
KEY WORDS: Chronic obstructive pulmonary disease, desaturation, interstitial lung disease, obstructive
sleep apnea, overnight pulse oximetry

INTRODUCTION
Hypoxemia results in a poor clinical outcome, making pulse oximetry an important tool to monitor patient
oxygenation routinely both in primary care and in hospital.[1] Overnight pulse oximetry (OPO) also has
emerged as one of the most widely used techniques to determine a patient's cardiopulmonary status, as it
provides adequate information about patient's oxygenation and respiratory patterns.

PRINCIPLE
Pulse oximetry is a spectrophotometry technology which determines the arterial oxygen saturation by the
detection of pulsatile blood flow and is based on differing absorption spectra of oxyhemoglobin and
deoxyhemoglobin which includes the red and near-infrared wavelengths of light.[2] The oxyhemoglobin
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absorbs near-infrared light and dissipates the red component of light which makes it appear bright red. On
the contrary, deoxyhemoglobin absorbs the red component of light more and scatters the near infrared,
making it look less red.[3]
Other wavelengths of the light such as the yellow, green, blue, and far infrared are absorbed by
nonvascular tissues. Based on this principle of differential absorption of light, pulse oximeters emit two
wavelengths of light, red at 660 nm and near infrared at 940 nm from two light-emitting diodes (LEDs)
located in one arm of the probe. A photoreceptor is present opposite to the LEDs with patient tissues with
a higher vascular density such as the finger, toes, nose, forehead, or earlobe held in between. This
photodiode detects the amount of red and near-infrared light absorbed by the vascular tissues from the light
transmitted through the finger held in between the arms of the probe. A large number of measurements of
relative light absorption are made multiple times every second, and these are fed into a microprocessor that
compares the ratio of absorption of the two spectra against a set of stored reference values in the form of a
calibration curve obtained empirically by measuring the relative red: infra-red modulation ratios in healthy
volunteers whose saturations were altered from 100% to approximately 70%. These values are accepted or
rejected using specific formulas. The microprocessor gives a new reading every 0.5–1 s that averages out
the readings over the last 3–6 s.[3]
Over the past few years, the advancement in technology has resulted in the possibility of continuous pulse
oximetry recording which gives a better idea of a patient's oxygenation and respiratory status. Generally,
continuous oximetry is done during the night time; hence, it is called OPO.
During a routine OPO, one can get an idea about the mean overnight saturation (mean SaO2) and lowest
SaO2 during the entire night recording. In general healthy controls, the normal overnight mean oxygen
saturation is 96%.[4] A decreased value points to an underlying cardiopulmonary problem.
Another parameter which is clinically helpful and is widely reported in most studies is time spent by the
patient, under 90% oxygen saturation (T-90) during the duration of the study. An elevated T-90 during
overnight sleep study represents the hypoxic burden during the study. It provides the clinician a clue of the
presence of coexistence of pulmonary hypertension, heart failure, and hypoventilation symptoms.
OPO has been used extensively in the field of sleep medicine and classified as a type 4 monitoring device.
[5,6] Its low cost, easy availability, and being able to perform it on an outpatient basis make this an
attractive alternative to polysomnographic studies for the screening of obstructive sleep apnea (OSA) in
patients with a high pretest suspicion.
Most clinicians also look at the oxygen saturation waveform patterns, which provide a good view of the
oxygenation status of the patient for the entire night's recording. In healthy controls, on OPO, the oxygen
saturation is maintained above 90% throughout the night [Figure 1]. One of the most typical patterns that
one can appreciate on OPO is the recognition of the relationship between rapid eye movement (REM)
sleep stage and occurrence of multiple clustered episodes of deep oxygen desaturation, also called
sawtooth pattern or “icicles from the rooftop” pattern [Figure 2], which is generally seen in the presence of
OSA.
One can also report on the number of oxygen desaturations (decrease of oxygen saturation by 4% from the
baseline per hour of recording) as an index, generally called oxygen desaturation index (ODI).[7] Various
authors have used different cutoff points for reporting ODI. The threshold for an abnormal ODI can be
either ≥5 desaturations per hour, ≥10 desaturations per hour, or ≥15 desaturations per hour.[1] It has been
demonstrated that in patients with a high pretest probability of OSA, ODI does correlate with the apneahypopnea index.[7,8,9]
Role of overnight pulse oximetry in screening for sleep-disordered breathing
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OSA syndrome or sleep-disordered breathing (SDB) is a major public health problem and has a rather
higher prevalence rate. Although polysomnography (PSG) is the gold standard for studying the sleep
quality and diagnosing SDB, it is expensive, time consuming, labor intensive, less readily available, and
requires regular monitoring and expertise for the interpretation. On the other hand, OPO can be used as a
quick and valuable screening tool.[10,11,12] It can be used as a case-selection technique to detect patients
who need PSG.[1,13]
Nocturnal pulse oximetry is a low-cost, safe, simple, convenient, noninvasive, and effective screening
method for SDB in adults.[11,14] It is readily and easily accessible with no risks or side effects to the
patients and has decreased the waiting time of OSA diagnosis.[11]
Apnea and hypopnea cause an arousal from sleep causing sympathetic activation, sleep disruption,
snoring, fatigue, nocturia, morning headaches, and excessive daytime sleepiness.[15] SDB leads to
increased risk of motor-vehicle crashes.[16] Several studies have shown that sleep apnea is associated with
hypertension, stroke, heart failure, obesity, metabolic syndrome,[17] diabetes,[18] neurocognitive deficits,
[19] gastroesophageal reflux disease,[20] and erectile dysfunction.[21] Such health problems can reduce
the quality of life. Chiang et al. have found OSA prevalence to be 60.9% among adult primary care
population who are at risk of OSA.[10] Hence, due to these effects of OSA and its increasing prevalence,
quick and accurate screening, diagnosis and treatment becomes very important.
Several studies have been done to evaluate the validity and usefulness of OPO in the screening of OSA [
Table 1]. Hang et al. studied a total of 616 patients with nocturnal oximetry and PSG study and showed
that OPO is a satisfactory diagnostic tool for patients with severe OSA.[11]
Others have also reported that in a population at high risk for OSA, OPO can be an effective screening
tool.[9,10,22,23,24] Romem et al. evaluated the accuracy of photoplethysmography (PPG)-based finger
pulse oximeter in the diagnosis of OSA. The study was performed on 73 patients with a likely diagnosis of
OSA using the PPG-based device and simultaneous in-laboratory PSG. It was concluded that the pulse
oximetry data were compared well with the PSG data.[6]
OPO has a role in the screening of OSA in obese patients too. Morbid obesity (BMI >40 kg/m2) leads to a
decreased basal nocturnal saturation due to the supine hypoventilation, hypoxemia, and hypercapnia
during sleep secondary to a large abdomen, reduced diaphragmatic excursions, and low chest wall
compliance.[25] These factors result in increased susceptibility to SDB. The OPO shows a combination of
low baseline oximetry (i.e., low T-90) and evidence of intermittent hypoxemia.
A study by Dumitrache-Rujinski et al. assessed the role of OPO in the screening of OSA in morbidly
obese patients. They prospectively evaluated 123 morbidly obese patients and 76 nonobese patients and
assessed the correlation between the overnight desaturation index obtained by the pulse oximetry and
apnea-hypopnea index measured by the PSG. ODI proved to be a useful tool as a screening method in
obese and nonobese patients.[14]
Netzer et al. in a review of OPO reported a wide range of sensitivity and specificity for predicting SDB
ranging from 31% to 98% and 41% to 100%, respectively.[1] Several possible reasons can be put forward
to explain these variations.[26] As reported by Böhning et al., there is an interdevice variability between
different pulse oximeters which may affect the quality of data and hence the study results.[27] In addition,
there is variability in how physicians interpret oximetry tracings and appears to be another limiting step
towards its wider use.[28]
In general, from the literature, it is clear that OPO allows for the screening for OSA in patients with
moderate-to-severe cases of OSA but is rather inadequate for the exclusion of milder cases. It is also
important to point however that oximetry testing cannot distinguish between OSA and central sleep apnea,
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so it is insufficient for the definitive diagnosis of OSA or qualify patients for therapy.[29] It should be
considered as a screening tool only for patients with high pretest suspicion. Patients who are found to have
suspicion of OSA will still need an overnight PSG or a home sleep study to confirm their diagnosis.
Others have also suggested that OPO can also be used to assess the response to continuous positive airway
pressure (CPAP) therapy and surgical treatment of OSA.[1,10] This is particularly helpful to establish the
improvement in ODI and T-90 once the patient has been treated for OSA.
Role of overnight pulse oximetry in the management of chronic obstructive pulmonary
disease
OSA and hypoxemia are commonly encountered in chronic obstructive pulmonary disease (COPD)
patients.[12] The sleep-related respiratory changes can prove to be dangerous in a patient of COPD due to
the reduced diaphragmatic excursion, ventilation-perfusion mismatch, and decreased chest wall
compliance.[30] Nocturnal hypoxemia can lead to cardiovascular complications and secondary pulmonary
hypertension.[31] The presence of nocturnal hypoxemia can easily be assessed with home OPO which
allows one to measure the T-90 value, which is the time at night spent below 90% oxygen saturation. In
general, one single OPO recording may not be enough to assess the nocturnal desaturation in COPD, as it
shows night-to-night variability.[32]
The overlap of COPD with OSA makes the diagnosis and prognosis very challenging.[33] It leads to poor
sleep and lower quality of life with increased morbidity and mortality. About 5–10% of COPD patients
have OSA, which is about 0.5–1% of the general population ≥40 years.[34,35] Patients with OSA and
hypoxemic COPD receiving long term oxygen therapy (LTOT) have higher survival rates when treated
with CPAP, as compared with those treated with LTOT only.[36] Nocturnal oximetry is an inexpensive
method to screen for OSA in patients with advanced COPD.[12] In addition, patients with COPD and OSA
that are being treated with CPAP can also be monitored with OPO for the adequacy of nocturnal
oxygenation.
Role of overnight pulse oximetry in the management of neuromuscular disorders
Neuromuscular respiratory failure in disorders such as amyotrophic lateral sclerosis (ALS) and muscular
dystrophies is characterized by daytime hypercapnia, dyspnea, and nocturnal hypoventilation (NH).[37]
This NH is an indication for noninvasive ventilation (NIV).[38,39] Hence, early detection of hypercapnia
and NH is important so that NIV can be timely initiated which would improve the quality of life in patients
of ALS.[40] NH is detected by lung function testing, PSG, or by exhaled PCO2 monitoring.[41,42]
However, PSG is not always feasible because it requires overnight stay in the sleep laboratories, and
patient at times may not be willing due to their special needs. Therefore, recently, a monitor that measures
transcutaneous PCO2 and SpO2 by pulse oximetry in a home setting has gained popularity. In a study by
Bauman et al. on 35 patients of neuromuscular disorders, home-based unsupervised monitoring of PCO2
and SpO2 proved to be a useful method for diagnosing NH.[37]
In a study by Elman et al., 87 nocturnal oximetry evaluations were done on 78 ALS patients symptomatic
for SDB. These measurements were compared for those with forced vital capacity (FVC) >50% versus
those with FVC of <50% of normal. A considerable number of these symptomatic patients showed
evidence of nocturnal hypoxemia by oximetry proving that FVC <50% is not the only criteria for starting
nocturnal nasal ventilation. Many patients can be hypoxemic and symptomatic at a higher FVC. Hence,
nocturnal oximetry helps to identify these patients for earlier respiratory intervention.[43] Nocturnal pulse
oximetry indirectly provides information about the arterial saturation in the night time and indirectly
provides information about the respiratory status. In patients with neuromuscular disorders, there is a
significant relationship between the decreased nocturnal saturation and daytime hypercapnia.[44]
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Although OPO is not a substitute for PSG, the low cost and convenience of this technique has stimulated
its application in ALS.[43,45,46] A mean nocturnal O2 saturation below 93% as detected by OPO is of
prognostic value in ALS.[46] Furthermore, NIV adapted to patients with early changes as registered by
OPO permitted a longer survival compared with a group of patients who started NIV when FVC declined
to 50% or less.[45]
The presence of significant nocturnal desaturation has been proposed as a parameter in decision-making
with regard to initiating home mechanical ventilation (HMV) or monitoring HMV effectiveness in patients
with neuromuscular disease, obesity, or chest wall deformity. The data obtained from nocturnal home pulse
oximetry and used in decision-making are the duration of the time with oxygen saturation SaO2 <90%
expressed as percentage (T-90) or in minutes (Tm90), mean SaO2, and lowest SaO2.[47]
Role of overnight pulse oximetry in the management of interstitial lung diseases
OPO becomes increasingly important in the evaluation of patients with interstitial lung diseases (ILDs)
because they exhibit abnormal sleep architecture with sleep fragmentation, SDB, and nocturnal oxygen
desaturation. Hypoxemia at night is common in patients of ILD even if there is no daytime resting
hypoxemia[48] and is linked to pulmonary hypertension and early mortality.[49,50] Therefore, correcting
nocturnal hypoxemia improves the quality of life and prevents pulmonary hypertension, which is one of
the strongest markers of a poor prognosis in ILD.[51] There exist no standard universally accepted criteria
of nocturnal hypoxemia in patients of ILD, but according to the Australia and New Zealand guidelines of
the treatment of idiopathic pulmonary fibrosis, nocturnal oxygen therapy is required in patients who
desaturate below 88% for at least one-third of the total sleep time in the absence of OSA.[52] Studies are
required to clarify the benefits of oxygen and to assess whether different thresholds for initiating nocturnal
oxygen are more appropriate, for example, SpO2 <90% for >10% of sleep time, according to the studies in
pulmonary hypertension.[50]
The patients of ILD have a rapid, shallow breathing pattern due to the impaired gas exchange across the
thickened, collagen-dense interstitium. The incidence of OSA is also high due to the increased upper
airway collapsibility and ventilatory control instability.[53,54]
Pihtili et al. studied the incidence of OSA in 17 patients with idiopathic pulmonary fibrosis (IPF), 15
patients with stage II–III sarcoidosis, and 18 patients with pulmonary fibrosis due to scleroderma. The
study showed 68% of the patients with OSA in this population. The prevalence of OSA was 82.3% in the
IPF patients, 66.6% in the sarcoidosis patients, and 55.5% in the scleroderma patients.[55] The OSArelated morbidity and mortality is high in ILD patients.[56]
Elevated nocturnal desaturation index strongly predicts the increased mortality in ILD patients, as the
nocturnal desaturation is proportional to the underlying interstitial fibrosis.[49] Hence, early diagnosis and
management is essential. PSG being an expensive procedure cannot be performed in all patients of OSA.
Therefore, nocturnal oximetry can be used to screen patients of ILD for the presence of SDB, and those
detected can be evaluated with an overnight PSG so that early CPAP treatment can be initiated.[57]

OTHER USES OF OVERNIGHT PULSE OXIMETRY
Pulse oximetry is safe to use in monitoring all patients, and generally, there are no contraindications.
Continuous pulse oximetry has a wide application in preoperative assessment, operating room surgeries,
postoperative recovery room, intensive care units, and stroke units.[1]

LIMITATIONS OF OVERNIGHT PULSE OXIMETRY
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Interpretation of the pulse oximetry data can be a challenging task. The user should have the knowledge of
normal oxygen saturation values during sleep.[1] Ayache and Strohl used a structured template for pulse
oximetry data interpretation by pulmonary and critical care fellows and concluded that the use of a
structured template produced a high interrater agreement and accuracy.[58]
As pulse oximetry measures pulsatile blood flow, poor perfusion and poor peripheral arterial blood flow
due to hypovolemic shock, hypothermia, cardiac failure, dysarrythmia, and peripheral vascular disease
affects its measurements.[1,3] Body movements such as during tremors and convulsions, vasoconstriction
and hypotension can cause artifacts as it interrupts the pulse signal. It does not always detect movement
artifacts so can overestimate desaturations.[1,3] Venous pulsations can also cause a falsely low SpO2
recording as the venous oxyhemoglobin saturation measured by the pulse oximeter lowers the arterial
saturation.[3] Pulse oximetry readings also depend on hemoglobin structure, so methemoglobinemia and
carboxyhemoglobinemia can cause high readings and severe anemia can lead to low readings. Dyes such
as methylene blue, indocyanine green, and indigo carmine used in diagnostic testing mimic the red light
absorption like deoxyhemoglobin and hence could cause falsely low readings.[3] Other causes of false low
readings are application of fingernail polish and the presence of abnormal hemoglobin variants in blood.[3]
In addition, pulse oximetry does not detect other types of SDB such as upper airway resistance syndrome
and pure central sleep apnea.[1] It is unable to score sleep quality.[11] It is important to recognize that the
accuracy of pulse oximeters deteriorates when the SpO2 falls below 80%.

CONCLUSION
OPO however still is a simple and low-cost “home monitoring device.”[59] It provides a rapid turnover of
nocturnal oxygen data in managing various cardiopulmonary disorders. With advancement in home
monitoring devices, this technology not only is cost-effective but also allows timely screening of patients
at risk of hypoxemia.
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Figure 1

Normal pulse oximetry
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Figure 2

Abnormal pulse oximetry
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Table 1
A selective review of overnight pulse oximetry in the patients of obstructive sleep apnea
Author/years/study

Dataset (n) Condition Aim

Gold standard

type
Hang et al./2015[11]

Technique

Results

(cutoff)
616 patients OSAS

Test the

Moderate OSA -

Overnight

ODI de

with

validity of

AHI=30, Severe OSA

oximetry

oximetr

suspected

overnight

- AHI=15

and Alice 4

Severe

OSAS

oximetry

PSG

accurac

for

recorder

90.42%

moderate-

sensitiv

to-severe

89.87%

OSA

specific
91.08%
modera
severe O
accurac
87.77%
sensitiv
88.53%
specific
86.56%

Vázquez et al./2000[9]

246 patients OSAS

Comparison AHI=15

In-

AHI ob

with

of results of

laboratory

from PS

suspected

pulse

PSG and

RDI ob

OSAS

oximetry

digital

from ox

and PSG

oximetry

highly c

recording

(R=0.97
oximetr
sensitiv
specific

Chiang et

Testing

PSG AHI 5-14

PSG and

60.9% (

al./2017[10]/Prospective males229

305

OSAS

overnight

events/h=mild OSA,

digital

patients

study

females

pulse

15-30=moderate OSA, oximetry

with risk

oximetry as >30=severe

factors for

a screening

OSAOxygen

of OSA

OSAS

tool for

desaturation defined

with ov

OSAS

d

d

recording

f 4%

positive
OSASe

l

Open in a separate window
OSA: Obstructive sleep apnea, OSAS: OSA syndrome, AHI: Apnea-Hypopnea index, PSG: Polysomnography, ODI:
Oxygen desaturation index, RDI: Respiratory disturbance index, ROC: Receiver-operating characteristic curve, PPV:
Positive predictive value; SDB: Sleep-disordered breathing, OPO: Overnight pulse oximetry, PPG:
Photoplethysmography, AF: Atrial fibrillation, COPD: Chronic Obstructive Pulmonary Disease, NA: Not available,
BMI: Body mass index
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